Discovering Deep Sleep Genes And Determining Their Roles For Preserving Cognitive Functions
Funder
National Health and Medical Research Council
Funding Amount
$484,901.00
Summary
Our mental well-being is largely tied to our sleep quality, and most cognitive disorders are also associated with poor sleep processes. Yet, we still do not know how sleep quality safeguards cognitive function. We will uncover genes that play a restorative role during deep sleep, and determine how genetic control of these deep sleep genes modulates selective attention in an animal model. Our results will suggest novel therapies for treating sleep disorders and associated diseases of the brain.
Sensory Cortex Processing Changes Underlying Brain And Behaviour Deficits Caused By Traumatic Brain Injury
Funder
National Health and Medical Research Council
Funding Amount
$576,795.00
Summary
Traumatic brain injury (TBI) from physical head trauma causes behavior and cognitive deficits. The burden for victims, families and the community is enormous: total life-time expenses in moderate-to-severe TBI are estimated to be $8.6 billion in Australia. We aim to elucidate whether changes in how the brain processes sensory information could underlie TBI-induced deficits in complex behaviour and whether these changes will be ameliorated by the three currently-most-promising treatments for TBI.
Unraveling The Neural Circuitry Of Context-induced Relapse To Alcohol Seeking After Punishment-imposed Abstinence
Funder
National Health and Medical Research Council
Funding Amount
$528,016.00
Summary
Alcohol use disorder (alcoholism) causes significant social and economic costs to Australian society. Alcoholism is a brain disease, and relapse during abstinence is the main problem in successful treatment. In this project, we use an animal model of relapse to alcohol seeking after abstinence imposed by a negative consequence (punishment). This project will identify brain regions which can be targeted in future clinical studies in human alcoholics.
Supraspinal Neural Adaptations In The Transition From Acute Injury To Chronic Pain And Disability
Funder
National Health and Medical Research Council
Funding Amount
$429,360.00
Summary
Although there have been significant clinical advances in the management of injury and the control of acute pain following tauma, many people still develop disabling conditions of chronic pain. Chronic pain and disability occurs even though the acute signs of trauma have subsided and injuries have healed. People with chronic pain conditions not only experience ongoing changes in sensation (ie., most commonly lowered thresholds for pain, touch evoked pain and spontaneous pain), they also endure a ....Although there have been significant clinical advances in the management of injury and the control of acute pain following tauma, many people still develop disabling conditions of chronic pain. Chronic pain and disability occurs even though the acute signs of trauma have subsided and injuries have healed. People with chronic pain conditions not only experience ongoing changes in sensation (ie., most commonly lowered thresholds for pain, touch evoked pain and spontaneous pain), they also endure a number of disabilities for example disrupted family and social relations, disturbed sleep, loss of appetite, weight changes, loss of sex drive, changes in menstrual cycle, the inability to cope with stressors, and often moderate to severe anxiety and depression. The proposed research aims to (i) identify changes in brain circuits which are responsible for producing these patterns of pain and disability following injury and (ii) attempts to selectively reverse some of these disabilities by reversing the brain changes. The results of this study will offer for the first time a rational basis for improving the outcomes of injury and pain management in the acute phase of trauma, by identifying and reversing the critical changes which predict the advent of the state state of chronic pain and disability.Read moreRead less
Are there common mechanisms for the inhibition of fear? Disorders of fear and anxiety affect up to 28% of Australians across their lives. This project studies how the brain inhibits fear and anxiety. It has four National Benefits. First, the knowledge generated by this project will contribute to coherent theoretical accounts of fear inhibition. Second, it will increase Australia's competitiveness and reputation in experimental psychology and behavioural neuroscience. Third, it will provide novel ....Are there common mechanisms for the inhibition of fear? Disorders of fear and anxiety affect up to 28% of Australians across their lives. This project studies how the brain inhibits fear and anxiety. It has four National Benefits. First, the knowledge generated by this project will contribute to coherent theoretical accounts of fear inhibition. Second, it will increase Australia's competitiveness and reputation in experimental psychology and behavioural neuroscience. Third, it will provide novel insights into ways of reducing anxiety and fear among sufferers of clinical anxiety disorders. Finally, it will provide internationally competitive training opportunities for Australian students.
Read moreRead less
The regulation of fear and attention: From genes to the brain to behaviour. Exposure to dangerous events elicits fear concomitant with attentional processing of environmental stimuli accompanying those events. However this fear and attention are typically inhibited so that they are restricted to dangerous events or stimuli which signal them. This project studies the role of endogenous opioids in the inhibition of fear and threat-related attention. It studies opioid inhibition in terms of its con ....The regulation of fear and attention: From genes to the brain to behaviour. Exposure to dangerous events elicits fear concomitant with attentional processing of environmental stimuli accompanying those events. However this fear and attention are typically inhibited so that they are restricted to dangerous events or stimuli which signal them. This project studies the role of endogenous opioids in the inhibition of fear and threat-related attention. It studies opioid inhibition in terms of its consequences for gene transcription, learning, and attention. It will provide the first integrated analysis of fear inhibition, from the level of the gene to the brain to behaviour. Thus, the project will provide significant insights into the biological complexity underpinning vulnerability to anxiety and fear.Read moreRead less
Predicting danger: The nature, consequences, and neural mechanisms of predictive fear learning. This project has four major national benefits. First, it addresses a fundamental scientific issue from a novel perspective to increase knowledge. By combining innovative approaches to study how the brain predicts danger, it will shed light on the relationship between brain and behaviour. Second, the project will contribute significantly to Australia's international competitiveness and reputation in ex ....Predicting danger: The nature, consequences, and neural mechanisms of predictive fear learning. This project has four major national benefits. First, it addresses a fundamental scientific issue from a novel perspective to increase knowledge. By combining innovative approaches to study how the brain predicts danger, it will shed light on the relationship between brain and behaviour. Second, the project will contribute significantly to Australia's international competitiveness and reputation in experimental psychology. Third, the knowledge generated by this project has the potential to improve the welfare of Australians by addressing an increasingly important health problem - anxiety. Finally, the project provides outstanding, internationally competitive, training opportunities for Australian students in Psychology.Read moreRead less
Relaxin-3/RXFP3 Signalling And Regulation Of Affective Behaviour _ Studies In Normal/transgenic Mice
Funder
National Health and Medical Research Council
Funding Amount
$578,268.00
Summary
Mental illness is a significant social and economic burden worldwide and knowledge of the underlying causes and more effective therapies are required. Our research aims to use pre-clinical animal models to characterize a little studied brain neuronal network implicated in control of arousal and stress, which could lead to improved treatment of psychiatric disorders such as depression.
My research is focused on understanding the aetiology of brain disorders. I am interested in the interaction of genetic and environmental factors in the development of these disorders. In particular, I will evaluate the validity of rodent models for schizophrenia and Alzheimer’s disease and investigate the therapeutic potential of the endocannabinoid system for both disorders and whether environmental enrichment (e.g. physical exercise) can have beneficial effects in these models.